AstraZeneca PLC
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
27.87%
Market Cap
246.28 Bil.
P/E Ratio
27.55
Dividend Yield
1.71 %
Earnings per Share
5.85 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 158.8 G | 0 Units |
| PRICE DETERMINATION TIME | 06/23/2026 / 09:56:27 PM | |
| DAILY VOLUME (UNITS) | 1,360 | |
| DAILY HIGH / LOW | 158.8 | 151.5 |
| PREV. DAY'S PRICE | 154.4 | (06/22) |
| CHANGE DAY BEFORE | +4.40 | 2.85 % |
| 52 WEEK HIGH / LOW | 180.65 (02/18) | 117.1 (07/21) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 10.05 | 8.96 | 5.85 | 4.20 | 3.56 |
| DIVIDENDS PER SHARE | 3.02 | 2.88 | 2.76 | 2.90 | 2.62 |
| DIVIDEND YIELD IN % | - | - | 1.71 % | 2.35 % | 2.15 % |
| DIVIDEND GROWTH IN % | - | - | -4.86 % | 10.75 % | -6.89 % |
| PRICE - EARNINGS RATIO | 15.19 | 17.03 | 27.55 | 29.47 | 34.27 |
| PRICE - BOOK RATIO | - | - | 5.91 | 4.98 | 5.35 |
| PRICE - SALES RATIO | - | - | 4.83 | 3.87 | 4.49 |
| PRICE - CASH FLOW RATIO | - | - | 19.10 | 17.13 | 19.36 |
Master Data
| WKN | 886455 |
| ISIN | GB0009895292 |
| SYMBOL | ZEG |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Astra Zeneca |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | British Pound Sterling |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 1.55 Bil. |
| MARKET CAPITALISATION | 246.28 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.92 % | -4.22 % | -2.59 % | -0.48 % | 27.87 % | 15.14 % | 57.99 % | -1.31 % |
| HIGH | 155.70 | 163.60 | 177.40 | 180.65 | 180.65 | 180.65 | 180.65 | 180.65 |
| LOW | 150.15 | 147.70 | 147.70 | 147.70 | 117.10 | 110.00 | 93.76 | 147.70 |
Dividend
per share
Company profile
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
Structured products for AstraZeneca PLC
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.